Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Chronic Pain in Elbow or Wrist
Unknown statusNot applicableNCT06207851
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In patients with chronic elbow or wrist pain, the pain is controlled by conventional conservative therapy The pain reduction effect of Nexsphere-F embolization in patients who need additional treatment It is intended to demonstrate safety.
Study details
- Official title
- A Single-arm, Single-center, Open-label, Pilot Clinical Study to Evaluate the Efficacy and Safety of Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Chronic Pain in Elbow or Wrist
- Conditions
- Interventions
- Device: Transcatheter Arterial Micro-Embolization
- Sponsor
- Next Biomedical Co., Ltd.
- Start date
- 2023-07-13
- Primary completion
- 2026-07-13
- Sex
- All
- Age range
- from 19 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Those aged 19 to 80 2. Anyone who can provide a consent form 3. A person with a life expectancy of at least 12 months 4. Those who have not responded or failed in preservation treatment for at least three months(e.g. NSAIDS/physical therapy/steroidal joint injections, etc.) 5. VAS score of 4 or higher and moderate-severe elbow or wrist pain Exclusion Criteria: 1. Those with a VAS Score of less than 4 and Mild Elbow or Wrist Pain 2. Chronic Renal Insufficiency(Serum creatinine \> 2mg/dL) 3. allergy to iodide contrast agents that do not respond to steroids 4. Those with acute infection or malignancy 5. Those who have previously had elbow or wrist surgery 6. Those with Bleeding Diabetes that cannot be calibrated
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06207851